JAMA Editors' Summary

Maintenance Infliximab for Immune-Mediated Inflammatory Diseases, Omega-3 Fatty Acids for Depression, DOACs and Atrial Fibrillation, and more

Dec 21, 2021
Ask episode
Chapters
Transcript
Episode notes